160 related articles for article (PubMed ID: 15052807)
1. [Diagnosis of and therapy for IgA nephropathy].
Tomino Y
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):483-7. PubMed ID: 15052807
[No Abstract] [Full Text] [Related]
2. [IgA nephropathy: from predicting progression to treatment].
Rauta V; Grönhagen-Riska C
Duodecim; 2006; 122(2):215-22. PubMed ID: 16509071
[No Abstract] [Full Text] [Related]
3. Modulating the progression in IgA nephropathy.
Chan JC; Trachtman H
Nephron Clin Pract; 2006; 104(1):c61-8. PubMed ID: 16741372
[TBL] [Abstract][Full Text] [Related]
4. [IgA nephropathy].
Tomino Y
Nihon Rinsho; 2005 May; 63 Suppl 5():516-20. PubMed ID: 15954402
[No Abstract] [Full Text] [Related]
5. IgA nephropathy.
Donadio JV; Grande JP
N Engl J Med; 2002 Sep; 347(10):738-48. PubMed ID: 12213946
[No Abstract] [Full Text] [Related]
6. [IgA nephropathy (immunoglobulin A nephropathy, M.Berger). Main symptoms: (painless) macrohematuria or microhematuria].
Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2004 Oct; 93(44):1809-13; quiz 1814. PubMed ID: 15559904
[No Abstract] [Full Text] [Related]
7. Immunoglobulin A nephropathy: a clinical perspective.
Donadio JV; Grande JP
J Am Soc Nephrol; 1997 Aug; 8(8):1324-32. PubMed ID: 9259362
[No Abstract] [Full Text] [Related]
8. IgA nephritis--ACE inhibitors, steroids etc?
Wardle EN
Nephrol Dial Transplant; 2007 Jun; 22(6):1785; author reply 1785. PubMed ID: 17403702
[No Abstract] [Full Text] [Related]
9. IgA nephropathy.
Wyatt RJ; Julian BA
N Engl J Med; 2013 Jun; 368(25):2402-14. PubMed ID: 23782179
[No Abstract] [Full Text] [Related]
10. [IgA-nephropathy: the most common type of glomerulonephritis].
Mertens PR; Floege J
Dtsch Med Wochenschr; 2003 May; 128(22):1242-6. PubMed ID: 12772083
[No Abstract] [Full Text] [Related]
11. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
12. [Guidelines for the treatment of childhood IgA nephropathy].
Yoshikawa N; Igarashi T; Ishikura K; Kaku Y; Nakazato H; Kamei K; Kawamura T; Nakamura H; Yamamoto Y; Nakanishi K; Sako M
Nihon Jinzo Gakkai Shi; 2008; 50(1):31-41. PubMed ID: 18318242
[No Abstract] [Full Text] [Related]
13. [IgA nephropathy--pathogenesis, pathophysiology, and therapy].
Narita I; Goto S; Kondo D; Sakatsume M; Gejyo F
Nihon Rinsho; 2006 Feb; 64 Suppl 2():397-402. PubMed ID: 16523921
[No Abstract] [Full Text] [Related]
14. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
Locatelli F; Vecchio LD; Pozzi C
Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
[TBL] [Abstract][Full Text] [Related]
15. Treatment of IgA nephropathy.
Pozzi C
J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
[TBL] [Abstract][Full Text] [Related]
16. Crescentic IgA nephropathy in a child: Effect of a new combination therapy.
Okamoto M; Yokoyama N; Nozu K; Nakanishi K; Yoshikawa N
Pediatr Int; 2017 Apr; 59(4):501-503. PubMed ID: 28244692
[No Abstract] [Full Text] [Related]
17. Corticosteroids plus ACE inhibitors for IgA nephropathy.
Bourry E; Gharbi C; Izzedine H
Nephrol Dial Transplant; 2010 Apr; 25(4):1351; author reply 1351-2. PubMed ID: 20157171
[No Abstract] [Full Text] [Related]
18. Glomerular disease: ACEIs with or without corticosteroids in IgA nephropathy?
Eitner F; Floege J
Nat Rev Nephrol; 2010 May; 6(5):252-4. PubMed ID: 20424626
[No Abstract] [Full Text] [Related]
19. [Therapeutic effects of RAS inhibitor in IgA nephropathy].
Kashihara N
Nihon Jinzo Gakkai Shi; 2008; 50(4):473-7. PubMed ID: 18546877
[No Abstract] [Full Text] [Related]
20. Treating IgA Nephropathy - Who, When and How?
Feehally J
Nephron Clin Pract; 2003; 93(2):C47-8. PubMed ID: 12616029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
